LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-09-22
Case ID: NM_002691.4_c.3218_4T_C_20260922_160733
Framework: ACMG/AMP 2015
Variant classification summary

NM_002691.4:c.3218+4T>C

POLD1  · NP_002682.2:p.?  · NM_002691.4
GRCh37: chr19:50920530 T>C  ·  GRCh38: chr19:50417273 T>C
Gene: POLD1 Transcript: NM_002691.4
Final call
VUS
PM2 supporting BP4 supporting
All criteria require review: For research and educational purposes only.
Gene
POLD1
Transcript
NM_002691.4
Protein
NP_002682.2:p.?
gnomAD AF
6.312549474606508e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: gnomAD v4.1 total allele frequency is 6.31e-06 (10/1,584,146 alleles, zero homozygotes) and the variant is absent from gnomAD v2.1.
2
BP4 supporting: SpliceAI maximum delta 0.025 is below the 0.1 threshold, so no splice-altering effect is predicted for this intronic donor +4 change.
3
VUS: one supporting pathogenic criterion plus one supporting benign criterion satisfies no ACMG/AMP 2015 combination rule.
Final determination: Under the generic ACMG/AMP 2015 rules, one supporting pathogenic criterion (PM2) together with one supporting benign criterion (BP4) satisfies no Pathogenic, Likely Pathogenic, Benign or Likely Benign combination, so the variant is classified as Variant of Uncertain Significance.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met Not met: c.3218+4T>C lies outside the canonical +/-1,2 donor site and SpliceAI max delta 0.025 predicts no aberrant splicing.
spliceai pvs1_variant_assessment pvs1_generic_framework pvs1_gene_context clinvar
PS1 N/A Not applicable: c.3218+4T>C is intronic with protein consequence p.?, producing no amino-acid change for a same-change comparison.
final_classification_framework clinvar pm5_candidates PMID:25394175
PS2 Not assessed Not assessed: no proband, parental testing, or pedigree data exists, so a confirmed de novo occurrence cannot be evaluated.
clinvar
PS3 Not met Not met: no functional assay of c.3218+4T>C exists - neither ClinVar submitter nor any retrieved full text reports a splice or protein-function study.
clinvar final_classification_framework PMID:17576681 PMID:9536098 PMID:25394175
PS4 Not met Not met: no case-control or cohort enrichment data exists for this variant, and no numeric PS4 threshold is available to compare against.
clinvar gnomad_v4 PMID:25394175
PM1 N/A Not applicable: c.3218+4T>C is intronic with protein consequence p.? and no occupied domain, and POLD1 has no VCEP domain table.
final_classification_framework pvs1_variant_assessment pm5_candidates clinvar
PM2 Met Met (supporting): gnomAD v4.1 all-comers AF 6.31e-06 (10/1,584,146 alleles, 0 homozygotes) and absent from v2.1, about 16-fold below the 0.0001 PM2 threshold.
gnomad_v4 gnomad_v2 clinvar generic_acmg_combination_rules
PM3 N/A Not applicable: POLD1 cancer predisposition is autosomal dominant (heterozygous loss-of-function), so the recessive in-trans PM3 criterion does not apply.
clinvar oncokb final_classification_framework
PM4 Not met Not met: this intronic substitution is not an in-frame indel or stop-loss, and SpliceAI 0.025 predicts no length-altering exon skipping.
spliceai pvs1_variant_assessment clinvar
PM5 N/A Not applicable: c.3218+4T>C is intronic with protein consequence p.?, so no residue exists and no same-residue comparator can be defined.
pm5_candidates final_classification_framework clinvar PMID:25394175
PM6 Not assessed Not assessed: with no proband or parental data, neither confirmed nor assumed de novo status can be established for this variant.
clinvar
PP1 Not assessed Not assessed: no pedigree, affected relatives, or genotype data, so PP1 co-segregation and meioses cannot be counted.
clinvar
PP2 N/A Not applicable: c.3218+4T>C is intronic with protein consequence p.?, not a missense variant, so this missense-specific gene criterion cannot apply.
final_classification_framework pvs1_gene_context pm5_candidates
PP3 Not met Not met: SpliceAI max delta 0.025 falls below the 0.2 supporting threshold for PP3.
spliceai
PP4 Not assessed Not assessed: no proband phenotype or family history is recorded anywhere in this case, so phenotype specificity for POLD1 disease cannot be judged.
clinvar pvs1_gene_context
PP5 Not met Not met: the only ClinVar submissions for this exact variant are two clinical-laboratory Uncertain significance calls with zero expert-panel submissions.
clinvar final_classification_framework
BA1 Not met Not met: gnomAD v4.1 all-comers AF 6.31e-06 (10/1,584,146 alleles), roughly four orders of magnitude below the 0.05 BA1 threshold.
gnomad_v4 gnomad_v2 generic_acmg_combination_rules
BS1 Not met Not met: gnomAD v4.1 AF 6.31e-06 versus the 0.01 BS1 threshold, roughly 1,500-fold below even using the highest-ancestry estimate.
gnomad_v4 gnomad_v2 generic_acmg_combination_rules
BS2 Not met Not met: zero homozygotes in gnomAD v4.1 (10/1,584,146 alleles) and POLD1 disease is adult-onset, incompletely penetrant cancer predisposition, so BS2's premise fails.
gnomad_v4 clinvar generic_acmg_combination_rules
BS3 Not met Not met: no functional study of c.3218+4T>C reports normal splicing or protein function; SpliceAI 0.025 is computational, not assay, evidence.
clinvar final_classification_framework PMID:17576681 PMID:9536098 PMID:25394175
BS4 Not assessed Not assessed: no family genotype data exists, so non-segregation cannot be demonstrated in this variant's relatives.
clinvar
BP1 N/A Not applicable: c.3218+4T>C is intronic with protein consequence p.?, not a missense variant, so the missense-specific BP1 cannot apply.
final_classification_framework pvs1_gene_context
BP2 Not met Not met: no phase data exist, so c.3218+4T>C was never observed in cis or in trans with a pathogenic POLD1 variant.
clinvar final_classification_framework
BP3 N/A Not applicable: BP3 covers in-frame indels in repeat regions, while this is a single-nucleotide intronic donor-site substitution.
pvs1_variant_assessment spliceai
BP4 Met Met at supporting: SpliceAI max delta 0.025 is at or below the 0.1 splice-impact BP4 threshold.
spliceai
BP5 Not assessed Not assessed: the case has no proband molecular or clinical data, so no alternate molecular basis for disease can be evaluated for BP5.
clinvar
BP6 Not met Not met: no expert-panel Benign/Likely benign classification exists for this exact variant, whose ClinVar entries are both Uncertain significance.
clinvar final_classification_framework
BP7 N/A Not applicable: c.3218+4T>C is an intronic donor-site change, not a synonymous variant.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.